SK Biopharmaceuticals Co., Ltd. (326030.KS) KSC
88,400.00
-700(-0.79%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
88,400.00
-700(-0.79%)
Currency In KRW
| Market Cap | 9.76T |
| Enterprise Value | 9.5T |
| P/E Ratio | 19.39 |
| PEG Ratio | 0.58 |
| Price/Sales Ratio | 8.76 |
| Price/Book Ratio | 7.26 |
| Enterprise/Revenue | 8.43 |
| Enterprise/EBITDA | 37.85 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.44 |
| Operating Margin | 0.34 |
| Return On Assets | 0.26 |
| Return On Equity | 0.46 |
| Revenue | 706.74B |
| Revenue/Share | 10,329.39 |
| Gross Profit | 651.67B |
| EBITDA | 220.89B |
| Net Income | 266.95B |
| Diluted EPS | 3,408.75 |
| Total Cash | 310.86B |
| Total Cash/Share | 4,063.28 |
| Total Debt | 49.98B |
| Total Debt/Equity | 0.05 |
| Current Ratio | 2.49 |
| Book Value Per Share | 12,182.89 |
| 52-Week Change | -2.96 |
| 52-Week High | 144,100 |
| 52-Week Low | 87,300 |
| Moving Average 50 Days | 98,182 |
| Moving Average 200 Days | 110,592.5 |
| Average Volume | 470,115 |
| Shares Outstanding | 78.31M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |